Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
6.50
-0.47 (-6.74%)
Feb 5, 2025, 10:29 AM EST - Market open
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $66.68 million as of February 5, 2025. Its market cap has decreased by -32.72% in one year.
Market Cap
66.68M
Enterprise Value
11.73M
1-Year Change
-32.72%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $66.68M, a decrease of -97.34%. That is a compound annual growth rate of -54.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2025 | 66.68M | -3.70% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.70B |
| UnitedHealth Group | 503.28B |
| Johnson & Johnson | 368.29B |
| Novo Nordisk | 367.70B |
| AbbVie | 336.15B |
| Merck & Co. | 225.01B |
| Thermo Fisher Scientific | 223.79B |
| Abbott Laboratories | 221.60B |